Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Intuitive SurgicalFRA:IUI -0.91%76 Debt-to-Equity is 0.00 as of Jun. 2026. GuruFocus rates FRA:IUI with a GF Score™ of 76/100 and a GF Value™ of €19.01 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 705 Medical Devices & Instruments companies, Intuitive Surgical ranks worse than 141843.83% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Intuitive Surgical's Debt-to-Equity or its related term are showing as below:
FRA:IUI's Debt-to-Equity is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.23 * Ranked among companies with meaningful Debt-to-Equity only.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Intuitive Surgical Debt-to-Equity Related Terms
Intuitive Surgical Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Intuitive Surgical's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:IUI vs BDX, MDLN, RMD: Debt-to-Equity Comparison
For the Medical Instruments & Supplies subindustry, Intuitive Surgical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Intuitive Surgical Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Intuitive Surgical's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Intuitive Surgical's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intuitive Surgical (FRA:IUI) has a Debt-to-Equity of 0.00 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Intuitive Surgical and its competitors. According to the industry distribution chart, Intuitive Surgical ranks #999999 out of 705 companies in the Medical Devices & Instruments industry.
Is Intuitive Surgical's Debt-to-Equity too high?
Intuitive Surgical's current Debt-to-Equity is 0.00. Based on the distribution chart, Intuitive Surgical ranks #999999 out of 705 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Intuitive Surgical has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Intuitive Surgical's Debt-to-Equity compare to BDX and MDLN?
According to the Medical Devices & Instruments industry distribution chart, Intuitive Surgical ranks #999999 out of 705 companies for Debt-to-Equity. This places Intuitive Surgical in the lower half of its industry. The industry median Debt-to-Equity is 0.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.23, based on 705 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Intuitive Surgical and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Intuitive Surgical's current Debt-to-Equity is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intuitive Surgical stock overvalued right now?
Based on GuruFocus' analysis, Intuitive Surgical (FRA:IUI) is currently considered Significantly Undervalued. The stock's GF Value™ is €19.01, compared to a current price of €10.90 — trading 42.7% below its estimated fair value. The current Debt-to-Equity is 0.00. Intuitive Surgical's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Intuitive Surgical (FRA:IUI), the current Debt-to-Equity is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Intuitive Surgical (FRA:IUI) Overvalued in 2026?
Based on GuruFocus' analysis, Intuitive Surgical stock appears to be undervalued.
The current stock price of €10.90 is trading 42.7% below its estimated GF Value™ of €19.01.
GuruFocus considers Intuitive Surgical to be Significantly Undervalued.
Key valuation signals for FRA:IUI:
Debt-to-Equity: 0.00
GF Value™: €19.01 vs. price of €10.90 (42.7% below fair value)
No single metric tells the full story. See the FRA:IUI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.
76GF Score
Get the complete analysis for FRA:IUI
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:IUI has been successfully added to your 
